Vermeulen M - Search Results

1

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study.

van Doorn PA, Brand A, Strengers PF, Meulstee J, Vermeulen M. van Doorn PA, et al. Among authors: vermeulen m. Neurology. 1990 Feb;40(2):209-12. doi: 10.1212/wnl.40.2.209. Neurology. 1990. PMID: 2405291 Clinical Trial.

2

Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro.

van Schaik IN, Lundkvist I, Vermeulen M, Brand A. van Schaik IN, et al. Among authors: vermeulen m. J Clin Immunol. 1992 Sep;12(5):325-34. doi: 10.1007/BF00920789. J Clin Immunol. 1992. PMID: 1430102

3

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement.

van Doorn PA, Vermeulen M, Brand A, Mulder PG, Busch HF. van Doorn PA, et al. Among authors: vermeulen m. Arch Neurol. 1991 Feb;48(2):217-20. doi: 10.1001/archneur.1991.00530140113024. Arch Neurol. 1991. PMID: 1847041

4

HLA antigens in patients with chronic inflammatory demyelinating polyneuropathy.

van Doorn PA, Schreuder GM, Vermeulen M, d'Amaro J, Brand A. van Doorn PA, et al. Among authors: vermeulen m. J Neuroimmunol. 1991 May;32(2):133-9. doi: 10.1016/0165-5728(91)90005-r. J Neuroimmunol. 1991. PMID: 1849516

5

On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy.

van Doorn PA, Rossi F, Brand A, van Lint M, Vermeulen M, Kazatchkine MD. van Doorn PA, et al. Among authors: vermeulen m. J Neuroimmunol. 1990 Sep-Oct;29(1-3):57-64. doi: 10.1016/0165-5728(90)90147-f. J Neuroimmunol. 1990. PMID: 2211989

6

The mechanism of action of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy.

Brand A, Van Doorn PA, Rossi F, Kazatchkine MD, Vermeulen M. Brand A, et al. Among authors: vermeulen m. Prog Clin Biol Res. 1990;337:405-9. Prog Clin Biol Res. 1990. PMID: 2353004 No abstract available.

7

Improvement in chronic inflammatory demyelinating polyradiculoneuropathy following gamma-globulin infusion.

van Doorn PA, Vermeulen M. van Doorn PA, et al. Among authors: vermeulen m. Arch Neurol. 1987 Sep;44(9):897-8. doi: 10.1001/archneur.1987.00520210005005. Arch Neurol. 1987. PMID: 2441685 No abstract available.

8

Chronic inflammatory demyelinating polyneuropathy. Conduction failure before and during immunoglobulin or plasma therapy.

van der Meché FG, Vermeulen M, Busch HF. van der Meché FG, et al. Among authors: vermeulen m. Brain. 1989 Dec;112 ( Pt 6):1563-71. doi: 10.1093/brain/112.6.1563. Brain. 1989. PMID: 2597997

9

Regulation of autoantibodies in inflammatory demyelinating polyneuropathy: spontaneous and therapeutic.

Lundkvist I, van Doorn PA, Vermeulen M, van Lint M, van Rood JJ, Brand A. Lundkvist I, et al. Among authors: vermeulen m. Immunol Rev. 1989 Aug;110:105-17. doi: 10.1111/j.1600-065x.1989.tb00029.x. Immunol Rev. 1989. PMID: 2676844 Review.

10

Anti-neuroblastoma cell line antibodies in inflammatory demyelinating polyneuropathy: inhibition in vitro and in vivo by IV immunoglobulin.

van Doorn PA, Brand A, Vermeulen M. van Doorn PA, et al. Among authors: vermeulen m. Neurology. 1988 Oct;38(10):1592-5. doi: 10.1212/wnl.38.10.1592. Neurology. 1988. PMID: 2843794

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,077 results

Search Page

Filters